Whitepapers

The inVia™ Qontor® microscope's optical tweezing performance depends on the optical properties of the particles and the medium. Typically, it can trap particles smaller than 10 ?m.

View a short podcast with Eurofins BioPharma Product Testing to learn how Eurofins overcomes the challenges faced in sterile fill finish manufacturing in the bio/pharmaceutical industry and solutions for producing small batches of sterile GMP or GLP products for use in Toxicology Studies, as well as Phase I or Phase II clinical trials by eliminating human error and other associated risks.

This paper explores raw material, formulation, process, and equipment design factors that potentially contribute to unexpected early API release from Wurster coated enteric particles.

CPI, a CDMO specializing in Wurster fluid bed coating, has designed and optimized equipment based on linear scaling principles, creating ease and predictability to scale-up.

Antibodies and proteins are critical reagents with wide application in in vitro diagnostic developments, companion diagnostic and biomarker assays. Depending on final application, different quality standards may apply, from research use to full GMP production. Learn more about Curia’s GMP Production of antibodies & proteins for critical assays and diagnostic applications.

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate from formulation development to clinical phase production and commercial manufacturing can be daunting. Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill-finish is successful. Learn more!

Protein engineering has greatly benefited by the advent of in vitro display platforms, where individual or large libraries of peptides or proteins are displayed on the surface of mammalian, yeast, or bacterial cells or even bacteriophage capsids. Learn more about the main principles of phage and yeast surface display platforms & how Curia can power your antibody discovery and engineering projects.

This white paper will highlight critical cleaning standards trending in controlled environments and profile the top cleaning products for COVID-19 and beyond.

The inVia™ Qontor® microscope's optical tweezing performance depends on the optical properties of the particles and the medium. Typically, it can trap particles smaller than 10 ?m.

This paper explores a Quality by Design (QbD) approach to applying Artificial Intelligence (AI) in pharma manufacturing, and demonstrates how to leverage third party platforms to qualify AI algorithms for pharmaceutical product and medical device productivity chains.

CPV will soon become a necessity in pharmaceutical manufacturing, if companies wish to retain a competitive advantage. This paper explores how to embed it into existing production processes to optimize the increasingly pervasive continuous manufacturing ecosystem of today

This application note demonstrates a streamlined HPLC method scouting workflow for the analysis of esomeprazole and related degradation products.

Multinational Biopharmaceutical Company Reduces Number of Downstream Ultrafiltration Recirculations via Predictive Analytics

Learn about how Aizon’s AI Consulting specializes in bringing innovative application of AI to bear as part of each customer’s journey of digital transformation.

Read this case study on a large global biotechnology company that was looking to explore predictive models to improve the yield of their downstream bioprocess using historical data.